Bioinvest Posts - TopicsExpress

PCYC – Pharmacyclics’ IMBRUVICA Gains FDA Approval For MCL,
PCYC – Pharmacyclics’ IMBRUVICA Gains FDA Approval For MCL, CLL; Coming Soon – Reiterate BUY LIMIT and TARGET PRICE – In a watershed moment f...

NVAX – ISCONOVA DEAL SOUND STRATEGIC MOVE – BUY NVAX AHEAD OF
NVAX – ISCONOVA DEAL SOUND STRATEGIC MOVE – BUY NVAX AHEAD OF CLOSING. Novavax announced today that as of yesterday (the initial Offer deadline),...

Incyte’s Jakafi Delivers Great Phase II Pancreatic Data: INCY
Incyte’s Jakafi Delivers Great Phase II Pancreatic Data: INCY has reported great top-line results from their Phase II, randomized, double-blind, pl...